A study for a 23 year old woman who takes Mercaptopurine, Pentasa - from FDA reports


128 females aged 23 (±5) who take the same drugs are studied. This is a personalized study for a 23 year old female patient who has Crohn's Disease. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Apr, 19, 2017

128 females aged 23 (±5) who takes Mercaptopurine, Pentasa are studied.

Number of reports submitted per year:

Mercaptopurine, Pentasa for a 23-year old woman.

Information of the patient in this study:

  • Age: 23
  • Gender: female
  • Conditions: Crohn's Disease
  • Drugs taken:
    • Mercaptopurine (mercaptopurine)
    • Pentasa (mesalamine)
  • Drug interactions: Leukopenia

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Leukopenia: 0 (0% of females aged 23 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Top conditions involved for these people *:

  • Crohn's Disease (76 people, 59.38%)
  • Ulcerative Colitis (25 people, 19.53%)
  • Birth Control (7 people, 5.47%)
  • Insomnia (5 people, 3.91%)
  • Depression (4 people, 3.12%)

Top co-used drugs for these people *:

  • Humira (57 people, 44.53%)
  • Prednisone (26 people, 20.31%)
  • Remicade (22 people, 17.19%)
  • Calcium (10 people, 7.81%)
  • Cimzia (9 people, 7.03%)

Top other side effects for these people *:

  • Fever (14 people, 10.94%)
  • Crohn's Disease (13 people, 10.16%)
  • Abdominal Pain (13 people, 10.16%)
  • Injection Site Pain (12 people, 9.38%)
  • Diarrhea (9 people, 7.03%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

What are the symptoms?

Could your drugs cause:

Could your conditions cause:

Related studies: